Onduo: Next Generation Chronic Disease/Diabetes Care
Follow Onduo on :
Vindell Washington, CEO, Onduo
As a dynamic, patient-driven industry, the healthcare sector is consistently reinventing its care delivery model to ensure superior returns in a patient’s care journey. Moving away from reactive treatment, healthcare organizations are embracing proactive and preventive care to support and help people living with chronic diseases in taking control of their condition. For diseases like type 2 diabetes that impacts more than eight percent of the world population and nearly 10 percent in the U.S. alone, a patient’s health status is mostly assessed through hospital visits and routine check-ups with physicians. Although regular glucose tests are instrumental, both patients and care providers need to have deeper insights to assess an individual’s health better as true healthcare occurs at home. Against this backdrop, Onduo has developed a new virtual care model that provides employers and health plans with solutions to empower people living with chronic conditions on their healthcare journey. With novel sensing devices, predictive analytics, digital interventions and behavioral science, the company aims to make healthcare accessible, actionable, and personalized beyond the boundaries of the physicians’ office.
With deep integration and support from its parent company Verily Life Sciences (an Alphabet company), Onduo collects and analyzes data to identify opportunities where intervention is likely to be successful and adapts its approach to provide patients with care that meets their individual needs. The company, which launched with the type 2 diabetes population, develops comprehensive solutions that combine technology and medical care for simple, personalized and data-driven disease management. For people with the highest risk of disease-related complications, Onduo focuses on helping them and supporting their providers through its virtual clinic. “We derive data from novel syncing devices, like the latest generation continuous glucose monitor for diabetes and several others that are deployed at homes and hospitals for monitoring conditions,” explains Vindell Washington, CEO of Onduo.
Depending on each member’s needs, interventions are offered in the form of guidance and support regarding diet, lifestyle habits, and medication management from different healthcare professionals such as Care Leads, certified diabetes educators, and clinical specialists like endocrinologists. Another unique arm of the program is its way of understanding when a patient is likely to respond to an intervention using the principles of behavioral economics and science. “We empower people to achieve their health and disease-related goals, such as reducing A1C and weight management. The key is for interventions to be as precise as any drug,” explains Washington. “Our model is based on meeting people where they are. If you want to change behavior, you have to identify opportunities where a person can adapt and figure out which interventions will be the best catalysts to drive individual change.”
According to the data published earlier this year and presented at the American Diabetes Association Scientific sessions, Onduo members have shown significant improvement in diabetes management, including notable reductions in hemoglobin A1C, which is otherwise difficult to control. Onduo has also been able to help people with diabetes manage their health holistically, even with co-morbidities, and optimize their medications while making sure they are on the right track to health. With the company’s holistic and precision-based approach, health plans, providers and employers can offer Onduo’s virtual care programs to help improve the health and quality of life status of their population, such as patients, members and employees.
Backed by a diverse team of behavioral and data scientists, as well as specialty medical clinicians, Onduo’s combined understanding of user needs drives them forward. With many successful outcomes in its repertoire, the company strives to enhance its solutions further and scale the virtual care model across the spectrum of healthcare by improving its predictive algorithm and using data to create an unprecedented digital footprint in the space. “Our aim is to reduce the burden of chronic disease by supporting providers, and bringing the care people need directly to them so they can live the life they want,” concludes Washington.
Change in A1c With and Without Intermittent Use of CGM In Adults With Type 2 Diabetes Participating in the Onduo Virtual Diabetes Clinic. Accepted for oral presentation: American Diabetes Association (ADA) 80th Scientific Sessions: A Virtual Experience, Chicago, Il, June 12-16, 2020.
Description We at Onduo are dedicated to making “healthy” easier, more accessible and finally personalized with our science-backed, data-driven virtual care model - one that can serve people living with chronic conditions and the organizations supporting them. Launched initially with the type 2 diabetes population and enabled by technology built by Verily Life Sciences, we deliver lifestyle and clinical interventions that leverage deep analytics, connected smart devices, best-in-class software, and access to specialty care. Onduo headquarters are based out of Newto, MA
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: